Effect of pharmaceutical care interventions on glycemic control in patients with diabetes: A systematic review and meta-analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Sohyun | - |
dc.contributor.author | Lee, Minhee | - |
dc.contributor.author | Ji, Eunhee | - |
dc.date.available | 2020-02-27T12:43:05Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2018-09 | - |
dc.identifier.issn | 1176-6336 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/4319 | - |
dc.description.abstract | Purpose: Diabetes is a chronic lifelong condition, and adherence to medications and self-monitoring of blood glucose are challenging for diabetic patients. The dramatic increase in the prevalence of diabetes is largely due to the incidence of type 2 diabetes in low-and middle-income countries (LMIc) besides high-income countries (HIc). We aimed to evaluate whether pharmacist care (PC) service model in LMIc and HIc could improve clinical outcomes in diabetic patients by performing a meta-analysis. Methods: PubMed, Embase, and ProQuest Dissertations Unlimited Published Literature database were searched to find publications pertaining to pharmacist-led intervention in patients with diabetes. The inclusion criteria were as follows: 1) randomized controlled trials, 2) confirmed diabetic patients (type 1 or type 2), 3) pharmaceutical care intervention by clinical pharmacist or/and multidisciplinary team, and 4) reporting HbA1c at baseline and end of study or the mean change in these values. Results: A total of 37 articles were included in the meta-analysis. The overall result was significant and in favor of PC intervention on HbA1c change (standard difference in mean values [SDM]: 0.379, 95% CI: 0.208–0.550, P<0.001). The stratified meta-analysis showed that PC was significant in both HIc (n=20; SDM: 0.351, 95% CI: 0.207–0.495) and LMIc (n=15; SDM: 0.426, 95% CI: 0.071–0.780). More than 6 months is needed to obtain adequate effects on clinical diabetes parameters. Conclusion: Our study presented that an adequate duration of pharmacist-led pharmaceutical care was effective in improving HbA1c in patients with diabetes in both LMIc and HIc. © 2018 Jeong et al. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Dove Medical Press Ltd. | - |
dc.relation.isPartOf | Therapeutics and Clinical Risk Management | - |
dc.title | Effect of pharmaceutical care interventions on glycemic control in patients with diabetes: A systematic review and meta-analysis | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000446767600002 | - |
dc.identifier.doi | 10.2147/TCRM.S169748 | - |
dc.identifier.bibliographicCitation | Therapeutics and Clinical Risk Management, v.14, pp.1813 - 1829 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85058494631 | - |
dc.citation.endPage | 1829 | - |
dc.citation.startPage | 1813 | - |
dc.citation.title | Therapeutics and Clinical Risk Management | - |
dc.citation.volume | 14 | - |
dc.contributor.affiliatedAuthor | Jeong, Sohyun | - |
dc.contributor.affiliatedAuthor | Lee, Minhee | - |
dc.contributor.affiliatedAuthor | Ji, Eunhee | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Diabetes | - |
dc.subject.keywordAuthor | High-income country | - |
dc.subject.keywordAuthor | Low-and middle-income country | - |
dc.subject.keywordAuthor | Multidisciplinary team care | - |
dc.subject.keywordAuthor | Pharmacist care | - |
dc.subject.keywordPlus | cholesterol | - |
dc.subject.keywordPlus | glucose | - |
dc.subject.keywordPlus | hemoglobin A1c | - |
dc.subject.keywordPlus | insulin | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | blood glucose monitoring | - |
dc.subject.keywordPlus | clinical outcome | - |
dc.subject.keywordPlus | diabetes mellitus | - |
dc.subject.keywordPlus | dietary intake | - |
dc.subject.keywordPlus | drug effect | - |
dc.subject.keywordPlus | exercise | - |
dc.subject.keywordPlus | follow up | - |
dc.subject.keywordPlus | glycemic control | - |
dc.subject.keywordPlus | high income country | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | insulin dependent diabetes mellitus | - |
dc.subject.keywordPlus | lifestyle modification | - |
dc.subject.keywordPlus | low income country | - |
dc.subject.keywordPlus | meta analysis | - |
dc.subject.keywordPlus | metabolic parameters | - |
dc.subject.keywordPlus | middle income country | - |
dc.subject.keywordPlus | non insulin dependent diabetes mellitus | - |
dc.subject.keywordPlus | patient care | - |
dc.subject.keywordPlus | patient counseling | - |
dc.subject.keywordPlus | patient education | - |
dc.subject.keywordPlus | patient referral | - |
dc.subject.keywordPlus | pharmacist | - |
dc.subject.keywordPlus | randomized controlled trial (topic) | - |
dc.subject.keywordPlus | systematic review | - |
dc.subject.keywordPlus | teleconsultation | - |
dc.subject.keywordPlus | treatment duration | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.